relcovaptan has been researched along with Menstruation, Painful in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beal, DM; Bryans, J; Dack, KN; Feeder, N; Harrison, A; Johnson, PS; Lewis, M; Mason, HJ; Mills, J; Newman, J; Pasquinet, C; Rawson, DJ; Roberts, LR; Russell, R; Ryckmans, T; Spark, D; Stobie, A; Underwood, TJ; Ward, R; Wheeler, S | 1 |
| Akerlund, M; Bossmar, T; Rasmussen, T | 1 |
| Akerlund, M; Bossmar, T; Brouard, R; Steinwall, M | 1 |
| Akerlund, M; Bossmar, T; Brouard, R; Chassard, D; Fournié-Lloret, D | 1 |
1 trial(s) available for relcovaptan and Menstruation, Painful
| Article | Year |
|---|---|
Effect of SR49059, an orally active V1a vasopressin receptor antagonist, in the prevention of dysmenorrhoea.
Topics: Administration, Oral; Adolescent; Adult; Antidiuretic Hormone Receptor Antagonists; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Dysmenorrhea; Female; Humans; Indoles; Pain Measurement; Pyrrolidines; Treatment Outcome | 2000 |
3 other study(ies) available for relcovaptan and Menstruation, Painful
| Article | Year |
|---|---|
Discovery of PF-184563, a potent and selective V1a antagonist for the treatment of dysmenorrhoea. The influence of compound flexibility on microsomal stability.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzodiazepines; Cytochrome P-450 Enzyme System; Drug Design; Drug Discovery; Drug Stability; Dysmenorrhea; Female; Hormone Antagonists; Humans; Microsomes; Molecular Structure; Triazoles | 2011 |
Effect of the non-peptide, vasopressin V1a receptor antagonist, SR 49059 and its enantiomer, SR 49770, on isolated human myometrium.
Topics: Arginine Vasopressin; Dysmenorrhea; Female; Hormone Antagonists; Humans; In Vitro Techniques; Indoles; Myometrium; Pyrrolidines; Vasoconstrictor Agents | 1996 |
Evidence for an involvement of vasopressin in mechanism of primary dysmenorrhea and effect of the non-peptide vasopressin V1a receptor antagonist, SR 49059, on the uterus of non-pregnant women.
Topics: Antidiuretic Hormone Receptor Antagonists; Dysmenorrhea; Endometrium; Female; Gene Expression Regulation; Hormone Antagonists; Humans; Indoles; Lypressin; Myometrium; Oxytocin; Pyrrolidines; Receptors, Vasopressin; Regional Blood Flow; Uterus | 1998 |